Journal of Alzheimer's Disease - Volume 81, issue 4

Authors: Zweig, Jonathan A. | Brandes, Mikah S. | Brumbach, Barbara H. | Caruso, Maya | Wright, Kirsten M. | Quinn, Joseph F. | Soumyanath, Amala | Gray, Nora E.

Article Type: Research Article

Abstract: Background: The medicinal herb Centella asiatica has been long been used for its neuroprotective and cognitive enhancing effects. We have previously shown that two weeks of treatment with a water extract of Centella asiatica (CAW) improves cognition and activates the endogenous antioxidant response pathway without altering amyloid-β (Aβ) plaque burden. Objective: Here, we assess the effect of long-term treatment of CAW in the 5xFAD mouse model of Aβ accumulation. Methods: Four-month-old 5xFAD mice were treated with CAW in their drinking water (2 g/L) for three months at which point they underwent cognitive testing as well …as analysis of Aβ plaque levels and antioxidant and synaptic gene expression. In order to confirm the involvement of the antioxidant regulatory transcription factor NRF2 on the effects of CAW on synaptic plasticity, neurons isolated from 5xFAD mice were also treated with CAW and the targeted inhibitor ML385. Results: Three months of treatment with CAW improved spatial and contextual memory as well as executive function in 5xFAD mice. This improvement was accompanied by increased antioxidant gene expression and a decrease in Aβ plaque burden relative to untreated 5xFAD animals. In isolated neurons, treatment with ML385 blocked the effects of CAW on dendritic arborization and synaptic gene expression. Conclusion: These results suggest that prolonged CAW exposure could be beneficial in Alzheimer’s disease and that these effects likely involve NRF2 activation. Moreover, these findings suggest that targeting NRF2 itself may be a relevant therapeutic strategy for improving synaptic plasticity and cognitive function in Alzheimer’s disease. Show more

Keywords: Alzheimer’s disease, amyloid-β, centella asiatica, cognition, NRF2

DOI: 10.3233/JAD-210271

Citation: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1453-1468, 2021

Authors: Huo, Qingwei | Tabassum, Sidra | Chen, Ming | Sun, Mengyao | Deng, Yueming | Zheng, Xingzhi | Li, Yi | Chen, Jian | Long, Cheng | Yang, Li

Article Type: Research Article

Abstract: Background: Neuropathological features of Alzheimer’s disease are characterized by the deposition of amyloid-β (Aβ) plaques and impairments in synaptic activity and memory. However, we know little about the physiological role of amyloid-β protein precursor (AβPP) from which Aβ derives. Objective: Evaluate APP deficiency induced alterations in neuronal electrical activity and mitochondrial protein expression. Methods: Utilizing electrophysiological, biochemical, pharmacological, and behavioral tests, we revealed aberrant local field potential (LFP), extracellular neuronal firing and levels of mitochondrial proteins. Result: We show that APP knockout (APP-/- ) leads to increased gamma oscillations in the medial prefrontal cortex …(mPFC) at 1-2 months old, which can be restored by baclofen (Bac), a γ-aminobutyric acid type B receptor (GABAB R) agonist. A higher dose and longer exposure time is required for Bac to suppress neuronal firing in APP-/- mice than in wild type animals, indicating enhanced GABAB R mediated activity in the mPFC of APP-/- mice. In line with increased GABAB R function, the glutamine synthetase inhibitor, L-methionine sulfonate, significantly increases GABAB R levels in the mPFC of APP-/- mice and this is associated with a significantly lower incidence of death. The results suggest that APP-/- mice developed stronger GABAB R mediated inhibition. Using HEK 293 as an expression system, we uncover that AβPP functions to suppress GABAB R expression. Furthermore, APP-/- mice show abnormal expression of several mitochondrial proteins. Conclusion: APP deficiency leads to both abnormal network activity involving defected GABAB R and mitochondrial dysfunction, suggesting critical role of AβPP in synaptic and network function. Show more

Keywords: Amyloid-β precursor protein, GABABR, gamma oscillations, L-methionine sulfonate, medial prefrontal cortex, mitochondria, spikes

DOI: 10.3233/JAD-201557

Citation: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1469-1482, 2021

Authors: Leroy, Victoire | Chen, Yaohua | Demnitz, Naiara | Pasquier, Florence | Krolak-Salmon, Pierre | Fougère, Bertrand | Puisieux, Françcois

Article Type: Research Article

Abstract: Background: Falls are a major health problem in older persons but are still under-diagnosed and challenging to prevent. Current guidelines do not target high-risk populations, especially people living with dementia. In France, people with neurocognitive disorders are mainly referred to memory clinics (MCs). Objective: We aimed to survey the routine practice of physicians working in MCs regarding fall risk assessment. Methods: We conducted a cross-sectional survey in France from January to May 2019 among physicians working in MCs, through an anonymous online questionnaire: twenty-seven questions about the physician’s background and their practice of fall risk assessment, …especially use of clinical and paraclinical tools. We compared the results according to the age and the specialty of the physician. Results: We obtained 171 responses with a majority of women (60%) and geriatricians (78%). All age classes and all French regions were represented. Most of respondents (98.8%) stated that they address gait and/or falls in outpatient clinic and 95.9%in day hospitals. When asked about how they assess fall risk, fall history (83%) and gait examination (68.4%) were the most widely used, while orthostatic hypotension (24%) and clinical standardized tests (25.7%) were less common. Among standardized tests, One-leg Balance, Timed Up and Go Test, and gait speed measurements were the most used. Geriatricians had more complete fall risk assessment than neurologists (e.g., 56%versus 13%for use of standardized tests, p  < 0.0001). Conclusion: Almost all physicians addressed the question of fall in MC, but practices are widely heterogeneous. Further investigations are needed to standardize fall risk assessment in MCs. Show more

Keywords: Assessment, fall risk, memory clinic, routine practice, survey

DOI: 10.3233/JAD-201585

Citation: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1483-1491, 2021

Authors: Pillai, Jagan A. | Kou, Lei | Bena, James | Penn, Lisa | Leverenz, James B.

Article Type: Research Article

Abstract: Background: There is significant interest in understanding the role of modifiable vascular risk factors contributing to dementia risk across age groups. Objective: Risk of dementia onset was assessed in relation to vascular risk factors of hypertension and hypercholesterolemia among cognitively normal APOE ɛ 4 carriers and non-carriers. Methods: In a sample of prospectively characterized longitudinal cohort from the National Alzheimer’s Coordinating Center database, 9,349 participants met criteria for normal cognition at baseline, had a CDR-Global (CDR-G) score of zero, and had concomitant data on APOE ɛ 4 status and medical co-morbidities including histories of …hypertension and hypercholesterolemia. Multivariable Cox proportional hazards models adjusted for well-known potential confounders were used to compare dementia onset among APOE ɛ 4 carriers and non-carriers by young (≤65 years) and old (> 65 year) age groups. Results: 519 participants converted to dementia within an average follow up of 5.97 years. Among older APOE ɛ 4 carriers, hypercholesterolemia was related to lower risk of dementia (HR (95% CI), 0.68 (0.49–0.94), p  = 0.02). Among older APOE ɛ 4 non-carriers, hypertension was related to higher risk of dementia (HR (95% CI), 1.44 (1.13–1.82), p  = 0.003). These results were corroborated among a subset with autopsy data characterizing underlying neuropathology. Among younger participants, vascular risk factors did not impact dementia risk, likely from a lower frequency of vascular and Alzheimer’s as etiologies of dementia among this cohort. Conclusion: A history of hypercholesterolemia related to a lower risk of dementia among older APOE ɛ 4 carriers, while hypertension related to a higher risk of dementia among older APOE ɛ 4 non-carriers. Show more

Keywords: APOE ɛ4, dementia, dementia risk, depression, hypercholesterolemia, hypertension, longitudinal cohort study, mixed dementia, neuropathology, normal cognition cohort

DOI: 10.3233/JAD-201609

Citation: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1493-1504, 2021

Authors: Dekker, Alain D. | Ulgiati, Aurora M. | Groen, Henk | Boxelaar, Vincent A. | Sacco, Silvia | Falquero, Ségolène | Carfi, Angelo | di Paola, Antonella | Benejam, Bessy | Valldeneu, Silvia | Fopma, Roelie | Oosterik, Marjo | Hermelink, Marloes | Beugelsdijk, Gonny | Schippers, Mieke | Henstra, Hepie | Scholten-Kuiper, Martine | Willink-Vos, Judith | de Ruiter, Lisa | Willems, Liesbeth | Loonstra-de Jong, Anneke | Coppus, Antonia M.W. | Tollenaere, Marleen | Fortea, Juan | Onder, Graziano | Rebillat, Anne-Sophie | Van Dam, Debby | De Deyn, Peter P.

Article Type: Research Article

Abstract: Background: People with Down syndrome (DS) are at high risk to develop Alzheimer’s disease dementia (AD). Behavioral and psychological symptoms of dementia (BPSD) are common and may also serve as early signals for dementia. However, comprehensive evaluation scales for BPSD, adapted to DS, are lacking. Therefore, we previously developed the BPSD-DS scale to identify behavioral changes between the last six months and pre-existing life-long characteristic behavior. Objective: To optimize and further study the scale (discriminative ability and reliability) in a large representative DS study population. Methods: Optimization was based on item irrelevance and clinical experiences …obtained in the initial study. Using the shortened and refined BPSD-DS II , informant interviews were conducted to evaluate 524 individuals with DS grouped according to dementia status: no dementia (DS, N = 292), questionable dementia (DS + Q, N = 119), and clinically diagnosed dementia (DS + AD, N = 113). Results: Comparing item change scores between groups revealed prominent changes in frequency and severity for anxious, sleep-related, irritable, restless/stereotypic, apathetic, depressive, and eating/drinking behavior. For most items, the proportion of individuals displaying an increased frequency was highest in DS + AD, intermediate in DS + Q, and lowest in DS. For various items within sections about anxious, sleep-related, irritable, apathetic, and depressive behaviors, the proportion of individuals showing an increased frequency was already substantial in DS + Q, suggesting that these changes may serve as early signals of AD in DS. Reliability data were promising. Conclusion: The optimized scale yields largely similar results as obtained with the initial version. Systematically evaluating BPSD in DS may increase understanding of changes among caregivers and (timely) adaptation of care/treatment. Show more

Keywords: Alzheimer’s disease, behavior, behavioral and psychological symptoms of dementia, dementia, Down syndrome, intellectual disabilities, neuropsychiatric symptoms, trisomy 21

DOI: 10.3233/JAD-201427

Citation: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1505-1527, 2021

Authors: Szlejf, Claudia | Suemoto, Claudia Kimie | Janovsky, Carolina Castro Porto Silva | Bertola, Laiss | Barreto, Sandhi Maria | Lotufo, Paulo Andrade | Benseñor, Isabela Martins

Article Type: Research Article

Abstract: Background: Subtle thyroid alterations have a controversial role in cognition. Objective: We investigated the longitudinal association of baseline thyroid function, thyrotropin (TSH), and thyroxine (FT4) levels with cognitive performance after 4 years of follow-up in middle-aged and older adults without overt thyroid dysfunction. Methods: We included 4,473 individuals, age≥55 years at the second study wave, without overt thyroid dysfunction at baseline. Individuals were divided according to thyroid function and TSH and FT4 tertiles. Cognition was assessed at baseline and after 4 years of follow-up by the word recall (DWR), semantic verbal fluency (SVF), and trail making …(TMT) tests. The longitudinal association of thyroid function and TSH and FT4 tertiles with cognitive performance was investigated using generalized estimating equations adjusted for sociodemographic characteristics, lifestyle, cardiovascular risk factors and depression. Results: There was no longitudinal association of thyroid function and TSH and FT4 baseline levels with performance on the cognitive tests. However, there was a baseline cross-sectional U-shaped association of FT4 tertiles with poorer performance in the SVF (first FT4 tertile: β = –0.11, 95% CI = –0.17; –0.04; third FT4 tertile: β = –0.10, 95% CI = –0.17; –0.04) and of the third FT4 tertile with poorer performance in the DWR (β = –0.09, 95% CI = –0.16; –0.02). Conclusion: Thyroid function and hormone levels were not associated with cognitive decline during 4 years of follow-up in middle-aged and older adults without overt thyroid dysfunction. Future studies with longer follow-up could clarify the implications of subtle thyroid alterations in cognition. Show more

Keywords: Cognition, free thyroxine, older adults, thyroid function, thyrotropin

DOI: 10.3233/JAD-210018

Citation: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1529-1540, 2021

Authors: Alegret, Montserrat | Espinosa, Ana | Ortega, Gemma | Pérez-Cordón, Alba | Sanabria, Ángela | Hernández, Isabel | Marquié, Marta | Rosende-Roca, Maitée | Mauleón, Ana | Abdelnour, Carla | Vargas, Liliana | de Antonio, Ester Esteban | López-Cuevas, Rogelio | Tartari, Juan Pablo | Alarcón-Martín, Emilio | Tárraga, Lluís | Ruiz, Agustín | Boada, Mercè | Valero, Sergi

Article Type: Research Article

Abstract: Background: Over the last decade, teleneuropsychology has increased substantially. There is a need for valid neuropsychological batteries to be administered home-to-home. Since 2006, the neuropsychological battery of Fundació ACE (NBACE) has been administered face-to-face in our clinical settings. Recently, we adapted the NBACE for teleneuropsychology use to be administered home-to-home (NBACEtn). Objective: The aims of the present study are: 1) to determine the home-to-home NBACE equivalence compared to its original face-to-face version; and 2) to examine home-to-home NBACE discriminant capacity by differentiating among cognitively healthy, mild cognitive impairment, or mild dementia subjects and comparing it with the face-to-face …version. Methods: Data from 338 individuals assessed home-to-home (NBACEtn) were contrasted with 7,990 participants assessed with its face-to-face version (NBACE). Exploratory and confirmatory factorial structure, and invariance analysis of the two versions of the battery were performed. Results: Exploratory and confirmatory factor analysis supported the four-factor model (attention, memory, executive, and visuospatial/constructional functions). Configural, metric, and scalar measurement invariance was found between home-to-home and face-to-face NBACE versions. Significant differences in most of the neuropsychological variables assessed were observed between the three clinical groups in both versions of administration. No differences were found between the technological devices used by participants (computer or tablet and mobile devices). Conclusion: For the first time, invariance analysis findings were addressed by determining a teleneuropsychological battery’s equivalence in comparison with its face-to-face version. This study amplifies the neuropsychological assessment’s applicability using a home-to-home format, maintaining the original measure’s structure, interpretability, and discriminant capacity. Show more

Keywords: Alzheimer’s disease, cognitive impairment, construct validity, face-to-face, home-to-home, invariance, neuropsychological assessment, telemedicine, teleneuropsychology

DOI: 10.3233/JAD-201389

Citation: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1541-1553, 2021

Authors: Molad, Jeremy | Hallevi, Hen | Korczyn, Amos D. | Seyman, Estelle | Bornstein, Natan M. | Niry, Dana | Eldor, Roy | Ben Assayag, Einor

Article Type: Research Article

Abstract: Background: Migraine is known to mildly increase the risk for ischemic stroke and is associated with vascular MRI markers. However, the potential effect of chronic headache (CH) on stroke outcomes has not been studied. Objective: We aimed to assess the interrelation between CH and post-stroke cognitive impairment. Methods: Data from 455 patients with a first ever stroke from the TABASCO study was available. All patients underwent 3T brain MRI, blood analysis, and a serial cognitive assessment at baseline and 6, 12, and 24 months after. Results: Eighty-five (18.7%) patients reported suffering from CH, of …whom 53 (62.4%) reported symptoms of photophobia or nausea, and 34 (40%) reported an aura. CH was associated with female sex, lower prevalence of T2DM (p  < 0.001), and lower HbA1C levels (p  < 0.001). Multiple regression analysis, controlling for age, sex, education, vascular risk factors, and the presence of acute lesions in MRI, revealed that CH was an independent predictor of better cognitive scores 6, 12, and 24 months post-stroke (p  = 0.015, p  = 0.01, and p  = 0.012, respectively). Stroke patients suffering from CH had also higher normalized gray, white matter, and thalamus volumes, and better white matter microstructural integrity (p  < 0.001, p  = 0.037, p  < 0.001, p  = 0.008, respectively) Conclusion: In this study, CH was consistently associated with better long term cognitive scores among post stroke subjects. These surprising findings may partially arise from the higher prevalence of T2DM among subjects without CH, that may represent the existence of chronic cerebrovascular disease, and may reflect mechanisms involving glucose metabolism. Show more

Keywords: Chronic headache, migraine, post-stoke cognitive impairment, stroke, TABASCO

DOI: 10.3233/JAD-210077

Citation: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1555-1566, 2021

Authors: Chekani, Farid | Pike, James | Jones, Eddie | Husbands, Joseph | Khandker, Rezaul K.

Article Type: Research Article

Abstract: Background: Dementia is commonly accompanied by neurobehavioral symptoms; however, the relationship between such symptoms and health-related outcomes is unclear. Objective: To investigate the impact of specific neurobehavioral symptoms in dementia on healthcare resource use (HCRU), patient quality of life (QoL), and caregiver burden. Methods: Data were taken from the 2015/16 Adelphi Real World Dementia Disease Specific Programme™, a point-in-time survey of physicians and their consulting dementia patients. Multiple regression analyses were used to examine associations between patient symptom groups and health-related outcomes. Results: Each patient symptom group of interest (patients with agitation/aggression and related …symptoms [AARS] with psychosis, patients with AARS without psychosis, and patients with other behavioral symptoms) had a positive association with HCRU variables (i.e., HCRU was greater), a negative association with proxy measures of patient QoL (i.e., QoL was decreased), and a positive association with caregiver burden (i.e., burden was greater) compared with patients with no behavioral symptoms (control group). The magnitude of effect was generally greatest in patients with AARS with psychosis. Regression analysis covariates that were found to be most often significantly related to the outcomes were dementia severity and the patients’ living situation (i.e., whether they were in nursing homes or living in the community). Conclusion: Combinations of behavioral symptoms, particularly involving AARS plus psychosis, may have a detrimental impact on health-related outcomes such as HCRU, patient QoL, and caregiver burden in dementia. Our results have implications for intervention development in patients who report clusters of symptoms and caregivers, and for identifying at-risk individuals. Show more

Keywords: Aggression, agitation, behavioral symptoms, burden, caregivers, cognitive impairment, dementia, healthcare resource use, quality of life

DOI: 10.3233/JAD-201483

Citation: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1567-1578, 2021

Authors: Nakamura, Shin | Yomota, Satoshi | Ito, Hitomi | Akinaga, Nobuyuki | Hori, Ayaka | Chinomi, Kenta | Suzuki, Hideaki | Uchida, Kazuhiko | Asada, Takashi

Article Type: Research Article

Abstract: Background: Maintaining cognitive function is integral to a healthy social life in the aged. Although neuropsychological tests and brain imaging methods can assess cognitive dysfunction, these techniques are subjective, psychologically burdensome, and cannot be conducted easily. Objective: We sought to develop an objective, low-burden novel cognitive function scale based on functional near-infrared spectroscopy (fNIRS) of hemodynamic changes in the cerebral cortex during daily task performance. Methods: A total of 63 participants (aged 60–80 years) identified as non-dementia controls (NDC) or with mild cognitive impairment (MCI) were recruited and randomly assigned to training and test data sets. …Explanatory variables were hemodynamic responses during low-burden sensory and simple tasks without higher-order brain functioning. Results: A logistic regression analysis of the fNIRS index in NDCs and MCI patients revealed area under the curve, sensitivity, specificity, and holdout results of 0.98, 94%, 88%, and 62% respectively. Correlation between fNIRS index and MCI odds showed positive linearity (R2  = 0.96). Conclusion: Positive correlation between the fNIRS index and MCI odds indicated effectiveness of this fNIRS measurement. Although additional experiments are necessary, the fNIRS index representing degree of cognitive decline can be an onsite monitoring tool to assess cognitive status. Show more

Keywords: Cognitive dysfunction, functional neuroimaging, mental status and dementia tests, neuropsychological tests, neurovascular coupling, spectroscopy near-infrared

DOI: 10.3233/JAD-210072

Citation: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1579-1588, 2021

Authors: Waller, Michael | Buckley, Rachel F. | Masters, Colin L. | Nona, Francis R. | Eades, Sandra J. | Dobson, Annette J.

Article Type: Research Article

Abstract: Background: The prevalence of dementia is generally reported to be higher among Indigenous peoples. Objective: The rates and coding of dementia mortality were compared between Indigenous and non-Indigenous Australians. Methods: De-identified individual records on causes of death for all people aged 40 years or more who died in Australia between 2006 and 2014 (n  = 1,233,084) were used. There were 185,237 records with International Classification of Diseases, Tenth Revision , codes for dementia (Alzheimer’s Disease, vascular dementia, or unspecified dementia) as the underlying cause of death or mentioned elsewhere on the death certificate. Death rates were compared …using Poisson regression. Logistic regression was used to assess whether dementia was more likely to be classified as ‘unspecified’ type in Indigenous Australians. Results: The rates of death with dementia were 57% higher in Indigenous Australians, compared to non-Indigenous, relative rate (RR) 1.57, 95% confidence interval (CI) (1.48, 1.66), p  < 0.0001. This excess of deaths was highest at ages below 75 (RRs > 2, test for interaction p  < 0.0001), and among men (test for interaction p  < 0.0001). When the underreporting of Indigenous status on the death certificate was taken into account the relative rate increased to 2.17, 95% CI (2.07, 2.29). Indigenous Australians were also more likely to have their dementia coded as ‘unspecified’ on their death certificate (Odds Ratio 1.92, 95% CI (1.66, 2.21), p  < 0.0001), compared to the non-Indigenous group. Conclusion: This epidemiological analysis based on population level mortality data demonstrates the higher dementia-related mortality rate for Indigenous Australians especially at younger ages. Show more

Keywords: Alzheimer’s disease, dementia, Indigenous, mortality, population-level studies, rural, unspecified dementia, vascular dementia

DOI: 10.3233/JAD-201175

Citation: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1589-1599, 2021

Authors: Kobayashi, Nobuyuki | Shinagawa, Shunichiro | Nagata, Tomoyuki | Tagai, Kenji | Shimada, Kazuya | Ishii, Azusa | Oka, Naomi | Shigeta, Masahiro | Kondo, Kazuhiro

Article Type: Research Article

Abstract: Background: Behavioral and psychological symptoms of dementia (BPSD) cause a heavy burden for both patient and caregivers. These symptoms are diverse, and their mechanism is still unclear. Agitation is the most common and difficult to treat among BPSD. In recent years, while changes in DNA methylation levels have been receiving attention as a biomarker of aging and dementia, associations with BPSD have not been examined. Objective: Focusing on agitation, the objective of the present study was to identify a region where changes in DNA methylation levels are associated with agitation. Methods: Using genome-wide DNA methylation analysis …data for 7 dementia subjects with agitation, 5 dementia subjects without agitation, and 4 normal elderly controls, we determined a signaling pathway in the WNT5A gene promoter region to be associated with agitation. Based on this result, we measured DNA methylation levels in this region for 26 dementia subjects with agitation and 82 dementia subjects without agitation by means of methylation-sensitive high-resolution melting (MS-HRM) analysis. Results: The WNT5A DNA methylation level in dementia subjects with agitation was significantly lower than in those without agitation (p  = 0.001). Changes in WNT5A DNA methylation levels were not influenced by age, sex, body mass index, APOE ɛ4, medication, or inflammatory cytokines. Conclusion: Our results suggested an association of agitation with Wnt signaling, in particular with changes in WNT5A DNA methylation levels, which could be a potentially useful biomarker for predicting the appearance of agitation. It may contribute to the elucidation of the mechanism of BPSD. Show more

Keywords: Alzheimer’s disease, behavioral and psychological symptoms of dementia, dementia, DNA methylation, epigenetics, Wnt signaling pathway, WNT5A

DOI: 10.3233/JAD-210078

Citation: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1601-1611, 2021

Authors: Almkvist, Ove | Brüggen, Katharina | Nordberg, Agneta

Article Type: Research Article

Abstract: Background: The effect of regional brain amyloid-β (Aβ) pathology on specific cognitive functions is incompletely known. Objective: The relationship between Aβ and cognitive functions was investigated in this cross-sectional multicenter study of memory clinic patients. Methods: The participants were patients diagnosed with Alzheimer’s disease (AD, n  = 83), mild cognitive impairment (MCI, n  = 60), and healthy controls (HC, n  = 32), who had been scanned by 11 C-PiB PET in 13 brain regions of both hemispheres and who had been assessed by cognitive tests covering seven domains. Results: Hierarchic multiple regression analyses were performed on each …cognitive test as dependent variable, controlling for demographic characteristics and APOE status (block 1) and PiB measures in 13 brain regions (block 2) as independent variables. The model was highly significant for each cognitive test and most strongly for tests of episodic memory (learning and retention) versus PiB in putamen, visuospatially demanding tests (processing and retention) versus the occipital lobe, semantic fluency versus the parietal lobe, attention versus posterior gyrus cinguli, and executive function versus nucleus accumbens. In addition, education had a positively and APOE status a negatively significant effect on cognitive tests. Conclusion: Five subcortical and cortical regions with Aβ pathology are differentially associated with cognitive functions and stages of disease in memory clinic patients. Show more

Keywords: Alzheimer’s disease, amyloid-β, cognitive functions, mild cognitive impairment, pittsburgh compound-B (PiB), positron emission tomography, regional Aβ pathology

DOI: 10.3233/JAD-201612

Citation: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1613-1624, 2021

Authors: Hunter, Matthew B. | Jenkins, Natalie | Dolan, Clare | Pullen, Hannah | Ritchie, Craig | Muniz-Terrera, Graciela

Article Type: Research Article

Abstract: Background: Telephone and videoconference administration of cognitive tests introduce additional sources of variance compared to in-person testing. Reviews of test-retest reliability have included mixed neurocognitive and psychiatric populations with limited consideration of methodological and statistical contributions. Objective: We reviewed reliability estimates from comparison studies of older adults with and without dementia, considering test-retest analyses and study methods. Methods: Medline, Embase, PsycINFO, and Web of Science were systematically searched from 1 January 2000 to 9 June 2020 for original articles comparing telephone or videoconference administered cognitive instruments to in-person administration in older adults with and without dementia …or mild cognitive impairment. Results: Of 4,125 articles, 23 were included: 11 telephone (N = 2 dementia cohorts) and 12 videoconference (N = 4 dementia cohorts). Telephone administered subtest scores trended in the same direction as in-person with comparable means. Person-level data were scarce. Data on dementia was only available for MMSE, with resulting subtle modality bias. MMSE, SMMSE, Letter Fluency, and HVLT-R in healthy to mild-moderate Alzheimer’s disease were particularly reliable for videoconference administration. Other tests show promise but require more observations and comprehensive analyses. Most studies used high-speed stable videoconferencing hardware resulting in a lack of ecological validity for home administration. Conclusion: Remote administration is often consistent with in-person administration but variable and limited at the person/test level. Improved statistical design and inclusion of dementia related cohorts in telephone studies is recommended. Reliability evidence is stronger for videoconferencing but with limited applicability to home administration and severe dementia. Improved reporting of administrative procedures is recommended. Show more

Keywords: Alzheimer’s disease, mild cognitive impairment, neuropsychological assessment, telehealth, telemedicine, teleneuropsychology

DOI: 10.3233/JAD-210088

Citation: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1625-1647, 2021

Authors: Hannestad, Jonas | Duclos, Tiffanie | Chao, Whitney | Koborsi, Katie | Klutzaritz, Vicki | Beck, Brian | Patel, Ashok K. | Scott, James | Thein, Stephen G. | Cummings, Jeffrey L. | Kay, Gary | Braithwaite, Steven | Nikolich, Karoly

Article Type: Research Article

Abstract: Background: The plasma fraction GRF6019 shows multiple benefits on brain aging in mice, including enhanced cognition, neurogenesis, and synaptic density, as well as reduced neuroinflammation. Objective: To evaluate the safety, tolerability, and preliminary efficacy of GRF6019 in patients with severe Alzheimer’s disease (AD). Methods: A phase II, double-blind, placebo-controlled study in patients with severe AD (Mini-Mental State Examination score 0–10). Patients were randomized 2 : 1 to GRF6019 (N = 18) or placebo (N = 8) and received daily 250 mL intravenous infusions over 5 days. The primary endpoints were the rates of adverse events (AEs) and the tolerability of GRF6019 as assessed …by the number of patients completing the study. Change from baseline in cognitive and functional assessments was also evaluated. Results: All patients completed 100%of study visits and infusions. The rate of AEs was similar in the GRF6019 (8/18 patients [44.4%]) and placebo (3/8 patients [37.5%]) groups, and there were no deaths or serious AEs. The most common AEs considered related to treatment were mild, transient changes in blood pressure in the GRF6019 group (hypotension: 2 patients [11.1%]; hypertension: 1 patient [5.6%]); there were no related AEs in the placebo group. The trial was not powered to detect statistically significant differences between treatment groups. At the end of the study, patients in both treatment groups remained stable or improved on all cognitive and functional endpoints. Conclusion: GRF6019 demonstrated excellent safety, feasibility, and tolerability. Future trials designed to characterize the potential functional benefits of GRF6019 and related plasma fractions in severe AD are warranted. Show more

Keywords: Aging, Alzheimer’s disease, blood proteins, dementia, plasma, randomized controlled trial

DOI: 10.3233/JAD-210011

Citation: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1649-1662, 2021

Authors: Subotic, Arsenije | McCreary, Cheryl R. | Saad, Feryal | Nguyen, Amanda | Alvarez-Veronesi, Ana | Zwiers, Angela M. | Charlton, Anna | Beaudin, Andrew E. | Ismail, Zahinoor | Pike, G. Bruce | Smith, Eric E.

Article Type: Research Article

Abstract: Background: Cerebral amyloid angiopathy (CAA) contributes to brain neurodegeneration and cognitive decline, but the relationship between these two processes is incompletely understood. Objective: The purpose of this study is to examine cortical thickness and its association with cognition and neurodegenerative biomarkers in CAA. Methods: Data were collected from the Functional Assessment of Vascular Reactivity study and the Calgary Normative Study. In total, 48 participants with probable CAA, 72 cognitively normal healthy controls, and 24 participants with mild dementia due to AD were included. Participants underwent an MRI scan, after which global and regional cortical thickness measurements …were obtained using FreeSurfer. General linear models, adjusted for age and sex, were used to compare cortical thickness globally and in an AD signature region. Results: Global cortical thickness was lower in CAA compared to healthy controls (mean difference (MD) –0.047 mm, 95% confidence interval (CI) –0.088, –0.005, p  = 0.03), and lower in AD compared to CAA (MD –0.104 mm, 95% CI –0.165, –0.043, p  = 0.001). In the AD signature region, cortical thickness was lower in CAA compared to healthy controls (MD –0.07 mm, 95% CI –0.13 to –0.01, p  = 0.02). Within the CAA group, lower cortical thickness was associated with lower memory scores (R2  = 0.10; p  = 0.05) and higher white matter hyperintensity volume (R2  = 0.09, p  = 0.04). Conclusion: CAA contributes to neurodegeneration in the form of lower cortical thickness, and this could contribute to cognitive decline. Regional overlap with an AD cortical atrophy signature region suggests that co-existing AD pathology may contribute to lower cortical thickness observed in CAA. Show more

Keywords: Alzheimer’s disease, cerebral amyloid angiopathy, cortical thickness, cognition, MRI, neurodegeneration

DOI: 10.3233/JAD-210138

Citation: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1663-1671, 2021

Authors: Du, Yan | Dennis, Brittany | Liu, Jia | Meyer, Kylie | Siddiqui, Nazish | Lopez, Katrina | White, Carole | Myneni, Sahiti | Gonzales, Mitzi | Wang, Jing

Article Type: Research Article

Abstract: Background: As the population rapidly ages, a growing number of families are engaging in care for individuals living with Alzheimer’s disease and related dementias (ADRD). The perceived challenges and burdens that face informal caregivers are enormous. Objective: The objective of this study was to 1) explore from the family caregivers’ perspective, the daily lives of individuals living with ADRD, and the challenges family caregivers encounter when caring for a family member with ADRD; and 2) to develop a comprehensive model with the endeavor to improve care for individuals with ADRD and their family caregivers. Methods: Posts …were extracted from the ALZConnected online caregiving forum in May 2019. Guided by a triangular model focused on Caregiver, Individual with ADRD , and Context of Care, two researchers independently analyzed 654 posts with a combination of deductive and inductive thematic analysis approach. Researchers all agreed on finalized codes and themes. Results: Thematic analysis resulted in four themes: Individual with ADRD , Caregiver, Dynamic between Caregiver and Individual with ADRD, and Context of Care . The most frequently discussed topics among caregivers were informational and emotional support for caregivers, and the capabilities and functioning of individuals with ADRD. Conclusion: Online forums provide a valuable platform for caregivers to support each other informationally and emotionally, share care strategies, and navigate caregiving burdens. An expanded model was derived to support a comprehensive and dynamic approach to improve care for both caregivers and individuals with ADRD. The unique nature of the caregiver forum data is worthy of further data mining using a novel analysis approach. Show more

Keywords: Alzheimer’s disease, caregiver, dementia, peer group, quality of life, support, technology

DOI: 10.3233/JAD-210167

Citation: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1673-1684, 2021

Authors: Ji, Mu-huo | He, Xue | Shen, Jin-chun | Yang, Jian-jun

Article Type: Research Article

Abstract: Background: Accumulating evidence has demonstrated that aging is associated with an exaggerated response to surgical trauma together with cognitive impairments. This has significant implications for the development of clinical phenotype such as perioperative neurocognitive disorders (PND), which is a common complication following surgery, especially for the elderly. However, the mechanism by which aging brain is vulnerable to surgical trauma remains to be elucidated. Objective: To test whether age-related alterations in hippocampal network activities contribute to increased risk of PND following surgery. Methods: Thirty-two adult and seventy-two aged male C57BL/6 mice undergone sevoflurane anesthesia and exploratory laparotomy …were used to mimic human abdominal surgery. For the interventional study, mice were treated with minocycline. Behavioral tests were performed post-surgery with open field, novel object recognition and fear conditioning tests, respectively. The brain tissues were then harvested and subjected to biochemistry studies. Local field potential (LFP) recording was performed in another separate experiment. Results: Aged mice displayed signs of neuroinflammation, as reflected by significantly increased proinflammatory mediators in the hippocampus. Also, aged mice displayed persistently decreased oscillation activities under different conditions, both before and after surgery. Further correlation analysis suggested that theta power was positively associated with time with novel object, while γ oscillation activity was positively associated with freezing time to context. Of note, downregulation of neuroinflammation by microglia inhibitor minocycline reversed some of these abnormities. Conclusion: Our study highlights that age-related hippocampal oscillation dysregulation increases the risk of PND incidence, which might provide diagnostic/prognostic biomarkers for PND and possible other neurodegenerative diseases. Show more

Keywords: Aging, cognitive function, inflammation, microglia, oscillation

DOI: 10.3233/JAD-201590

Citation: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1685-1699, 2021

Authors: Xu, Wei | Tan, Chen-Chen | Zou, Juan-Juan | Cao, Xi-Peng | Tan, Lan | for the Alzheimer’s Disease Neuroimaging Initiative

Article Type: Research Article

Abstract: Background: It is suggested that not all individuals with elevated Aβ will develop dementia or cognitive impairment. Environment or lifestyle might modulate the association of amyloid pathology with cognition. Insomnia is a risk factor of cognitive disorders including Alzheimer’s disease. Objective: To investigate if insomnia moderated the relationship between amyloid-β (Aβ) and longitudinal cognitive performance in non-demented elders. Methods: A total of 385 Alzheimer’s Disease Neuroimaging Initiative participants (mean age = 73 years, 48% females) who completed 4 + neuropsychological evaluations and a [18 F] florbetapir positron emission tomography scan were followed up to 8 years. Linear mixed-effects regression models …were used to examine the interactions effect between insomnia and Aβ on longitudinal cognitive sores, including four domains (memory [MEM], executive function [EF], language [LAN], and visuospatial function [VS]). Results: The Aβ-positive status (A +) but not insomnia independently predicted faster cognitive decline in all domains. Furthermore, the relationship between Aβ and cognitive decline was moderated by insomnia (MEM: χ 2  = 4.05, p  = 0.044, EF: χ 2  = 4.38, p  = 0.036, LAN: χ 2  = 4.56, p  = 0.033, and VS: χ 2  = 4.12, p  = 0.042). Individuals with both elevated Aβ and insomnia experienced faster cognitive decline than those with only elevated Aβ or insomnia. Conclusion: These data reinforced the values of insomnia management in preventing dementia, possibly by interacting Aβ metabolism. Future efforts are warranted to determine whether sleep improvement will postpone the onset of dementia, specifically among populations in stages of preclinical or prodromal AD. Show more

Keywords: Amyloid-β , cognition, insomnia, interaction, longitudinal

DOI: 10.3233/JAD-201582

Citation: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1701-1710, 2021

Authors: Bangen, Katherine J. | Thomas, Kelsey R. | Sanchez, Danielle L. | Edmonds, Emily C. | Weigand, Alexandra J. | Delano-Wood, Lisa | Bondi, Mark W. | for the Alzheimer’s Disease Neuroimaging Initiative

Article Type: Research Article

Abstract: Background: Altered cerebral blood flow (CBF) has been linked to increased risk for Alzheimer’s disease (AD). However, whether altered CBF contributes to AD risk by accelerating cognitive decline remains unclear. It also remains unclear whether reductions in CBF accelerate neurodegeneration and development of small vessel cerebrovascular disease. Objective: To examine associations between CBF and trajectories of memory performance, regional brain atrophy, and global white matter hyperintensity (WMH) volume. Method: 147 Alzheimer’s Disease Neuroimaging Initiative participants free of dementia underwent arterial spin labeling (ASL) magnetic resonance imaging (MRI) to measure CBF and serial neuropsychological and structural MRI …examinations. Linear mixed effects models examined 5-year rate of change in memory and 4-year rate of change in regional brain atrophy and global WMH volumes as a function of baseline regional CBF. Entorhinal and hippocampal CBF were examined in separate models. Results: Adjusting for demographic characteristics, pulse pressure, apolipoprotein E ɛ4 positivity, cerebrospinal fluid p-tau/Aβ ratio, and neuronal metabolism (i.e., fluorodeoxyglucose standardized uptake value ratio), lower baseline entorhinal CBF predicted faster rates of decline in memory as well as faster entorhinal thinning and WMH progression. Hippocampal CBF did not predict cognitive or brain structure trajectories. Conclusion: Findings highlight the importance of early cerebrovascular dysfunction in AD risk and suggest that entorhinal CBF as measured by noninvasive ASL MRI is a useful biomarker predictive of future cognitive decline and of risk of both Show more

Keywords: Aging, Alzheimer’s disease, cognition, entorhinal cortex regional blood flow, magnetic resonance imaging, neuropsychology, perfusion, white matter hyperintensities

DOI: 10.3233/JAD-201474

Citation: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1711-1725, 2021

Authors: Camargo, Aldo | Wang, Ze | for the Alzheimer’s Disease Neuroimaging Initiative

Article Type: Research Article

Abstract: Background: Cross-sectional studies have shown lower cerebral blood flow (CBF) in Alzheimer’s disease (AD), but longitudinal CBF changes in AD are still unknown. Objective: To reveal the longitudinal CBF changes in normal control (NC) and the AD continuum using arterial spin labeling perfusion magnetic resonance imaging (ASL MRI). Methods: CBF was calculated from two longitudinal ASL scans acquired 2.22±1.43 years apart from 140 subjects from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). At the baseline scan, the cohort contained 41 NC, 74 mild cognitive impairment patients (MCI), and 25 AD patients. 21 NC converted into MCI and …17 MCI converted into AD at the follow-up. Longitudinal CBF changes were assessed using paired-t test for non-converters and converters separately at each voxel and in the meta-ROI. Age and sex were used as covariates. Results: CBF reductions were observed in all subjects. Stable NC (n  = 20) showed CBF reduction in the hippocampus and precuneus. Stable MCI patients (n  = 57) showed spatially more extended CBF reduction patterns in hippocampus, middle temporal lobe, ventral striatum, prefrontal cortex, and cerebellum. NC-MCI converters showed CBF reduction in hippocampus and cerebellum and CBF increase in caudate. MCI-AD converters showed CBF reduction in hippocampus and prefrontal cortex. CBF changes were not related with longitudinal neurocognitive changes. Conclusion: Normal aging and AD continuum showed common longitudinal CBF reductions in hippocampus independent of disease and its conversion. Disease conversion independent longitudinal CBF reductions escalated in MCI subjects. Show more

Keywords: Aging, Alzheimer’s disease, arterial spin labeling, cerebral blood flow, longitudinal analysis

DOI: 10.3233/JAD-210116

Citation: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1727-1735, 2021

Authors: Koyanagi, Ai | Smith, Lee | Shin, Jae Il | Oh, Hans | Kostev, Karel | Jacob, Louis | Abduljabbar, Adel S. | Haro, Josep Maria

Article Type: Research Article

Abstract: Background: Data on the association between multimorbidity and subjective cognitive complaints (SCC) are lacking from low- and middle-income countries (LMICs). Objective: To assess the association between multimorbidity and SCC among adults from 48 LMICs. Methods: Cross-sectional, community-based data were analyzed from the World Health Survey 2002–2004. Ten chronic conditions (angina, arthritis, asthma, chronic back pain, depression, diabetes, edentulism, hearing problems, tuberculosis, visual impairment) were assessed. Two questions on subjective memory and learning complaints in the past 30 days were used to create a SCC scale ranging from 0 (No SCC) to 100 (worse SCC). Multivariable linear …regression and mediation analyses were conducted to explore the associations. Results: A total of 224,842 individuals aged≥18 years [mean (SD) age 38.3 (16.0) years; 49.3% males] constituted the final sample. Compared to no chronic conditions, the mean SCC score was higher by 7.13 (95% CI = 6.57–7.69), 14.84 (95% CI = 13.91–15.77), 21.10 (95% CI = 19.49–22.70), 27.48 (95% CI = 25.20–29.76), and 33.99 (95% CI = 31.45–36.53) points for 1, 2, 3, 4, and≥5 chronic conditions. Estimates by sex and age groups (18–44, 45–64,≥65 years) were similar. Nearly 30% of the association between multimorbidity (i.e.,≥2 chronic conditions) and SCC was explained by psychological factors (i.e., perceived stress, sleep problems, anxiety symptoms). Conclusion: Multimorbidity is associated with SCC among adults in LMICs. Future studies should investigate whether addressing psychological factors in people with multimorbidity can improve cognitive function, and whether screening for SCC in individuals with multimorbidity can be a useful tool to identify individuals at particularly high risk for future cognitive decline. Show more

Keywords: Chronic physical conditions, low- and middle-income countries, multimorbidity, subjective cognitive complaints

DOI: 10.3233/JAD-201592

Citation: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1737-1747, 2021

Authors: Du, Fang | Yu, Qing | Yan, Shirley ShiDu

Article Type: Research Article

Abstract: Background: Mitochondrial dysfunction, bioenergetic deficit, and extensive oxidative stress underlie neuronal perturbation during the early stage of Alzheimer’s disease (AD). Previously, we demonstrated that decreased PTEN-induced putative kinase 1 (PINK1) expression is associated with AD pathology in AD-affected human brains and AD mice. Objective: In the present study, we highlight the essential role of PINK1 in AD-relevant mitochondrial perturbation and neuronal malfunction. Methods: Using trans-mitochondrial “cybrid” (cytoplasmic hybrid) neuronal cells, whose mitochondria are transferred from platelets of patients with sporadic AD, we observed the effect of PINK1 in neuronal-like differentiation and synaptogenesis and mitochondrial functions. …Results: In AD cybrid cells, the downregulation of PINK1 is correlated to the alterations in mitochondrial morphology and function and deficit in neuronal-like differentiation. Restoring/increasing PINK1 by lentivirus transduction of PINK1 robustly attenuates mitochondrial defects and rescues neurite-like outgrowth. Importantly, defective PINK1 kinase activity fails to reverse these detrimental effects. Mechanistically, AD cybrid cells reveal a significant decrease in PINK1-dependent phosphorylated mitofusin (Mfn) 2, a key mitochondrial membrane protein that participates in mitochondrial fusion, and an insufficient autophagic activity for the clearance of dysfunctional mitochondria. Overexpression of PINK1, but not mutant PINK1 elevates phosphorylation of Mfn2 and autophagy signaling LC3-II. Accordingly, PINK1-overexpressed AD cybrids exhibit increases in mitochondrial length and density and suppressed reactive oxygen species. These results imply that activation of PINK1 protects against AD-affected mitochondrial dysfunction and impairment in neuronal maturation and differentiation. Conclusion: PINK1-mediated mitophagy is important for maintaining mitochondrial health by clearance of dysfunctional mitochondria and therefore, improves energy homeostasis in AD. Show more

Keywords: Alzheimer’s disease, cybrid cells, mitochondrial dysfunction, mitophagy, PINK1

DOI: 10.3233/JAD-210095

Citation: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1749-1761, 2021

Authors: Hirsch, Joseph A. | Cuesta, George M. | Fonzetti, Pasquale | Comaty, Joseph | Jordan, Barry D. | Cirio, Rosanna | Levin, Leanne | Abrahams, Alex | Fry, Kathleen M.

Article Type: Research Article

Abstract: Background: Auditory naming tests are superior to visual confrontation naming tests in revealing word-finding difficulties in many neuropathological conditions. Objective: To delineate characteristics of auditory naming most likely to reveal anomia in patients with dementia, and possibly improve diagnostic utility, we evaluated a large sample of patients referred with memory impairment complaints. Methods: Patients with dementia (N  = 733) or other cognitive impairments and normal individuals (N  = 69) were evaluated for frequency of impairment on variables of the Auditory Naming Test (ANT) of Hamberger & Seidel versus the Boston Naming Test (BNT). Results: Naming impairment …occurred more frequently using the ANT total score (φ = 0.41) or ANT tip-of-the tongue score (TOT; φ = 0.19) but not ANT mean response time compared to the BNT in patients with dementia (p  < 0.001). Significantly more patients were impaired on ANT variables than on the BNT in Alzheimer’s disease (AD), vascular dementia (VaD), mixed AD/VaD, and multiple domain mild cognitive impairment (mMCI) but not in other dementias or amnestic MCI (aMCI). This differential performance of patients on auditory versus visual naming tasks was most pronounced in older, well-educated, male patients with the least cognitive impairment. Impaired verbal comprehension was not contributory. Inclusion of an ANT index score increased sensitivity in the dementia sample (92%). Poor specificity (41%) may be secondary to the inherent limitation of using the BNT as a control variable. Conclusion: The ANT index score adds diagnostic utility to the assessment of naming difficulties in patients with suspected dementia. Show more

Keywords: Alzheimer’s disease, anomia, auditory naming, boston naming test, dementia, mild cognitive impairment, neuropsychological assessment, word-finding

DOI: 10.3233/JAD-210322

Citation: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1763-1779, 2021

Authors: Hoffmann, Jessica | Busse, Stefan | von Hoff, Franz | Borucki, Katrin | Frodl, Thomas | Busse, Mandy

Article Type: Research Article

Abstract: Background: Although it is known that the nutritional status among elderly persons and, in particular, patients with dementia, is compromised, malnutrition that results in insufficient uptake of several vitamins is often not diagnosed. Objective: An elevated homocysteine level is a known strong risk factor for vascular dementia (VaD) and Alzheimer’s disease (AD). Several B vitamins are involved in the metabolism of homocysteine. Therefore, we investigated the serum levels of vitamin B1, vitamin B6, folate, and vitamin B12 in 97 patients with mild cognitive impairment (MCI) or different forms of dementia and 54 elderly control persons without dementia. …Results: Compared to aged non-demented people, vitamins B1, B6, B12, and folate were decreased in serum of patients with AD, and patients with Lewy body dementia had reduced vitamin B12 level. Vitamin B6 was diminished in VaD. Patients with frontotemporal dementia showed no alterations in vitamin levels. Age was identified as an important factor contributing to the concentrations of vitamin B1 and B6 in serum, but not vitamin B12 and folate. Increased levels of total homocysteine were detected especially in MCI and AD. Homocysteine correlated negatively with levels of vitamins B6, B12, and folate and positively with Q Albumin. Conclusion: Our data suggest that despite increased homocysteine already present in MCI, vitamin levels are decreased only in dementia. We propose to determine the vitamin levels in patients with cognitive decline, but also elderly people in general, and recommend supplementing these nutrients if needed. Show more

Keywords: B vitamins, dementia, homocysteine

DOI: 10.3233/JAD-201481

Citation: Journal of Alzheimer's Disease, vol. 81, no. 4, pp. 1781-1792, 2021